 Home > Medical News > Latest Medical News > The clinical trial application of Ganlai FXR agonist in the treatment of primary biliary cholangitis was accepted by NMPA

The clinical trial application of Ganlai FXR agonist in the treatment of primary biliary cholangitis was accepted by NMPA

 Last Update: 2021-09-12
 Source: Internet
 Author: User

Tags

drug resistant malaria

gaba agonist drugs

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On September 6, Gan Lai Pharmaceutical, a wholly-owned subsidiary of Golly Pharmaceuticals, announced that the clinical trial application of ASC42 for the treatment of patients with primary biliary cholangitis (PBC) has been accepted by the State Food and Drug Administration of China

ASC42 is a non-steroidal FXR agonist.

According to the "Standards for the diagnosis and treatment of primary biliary cholangitis (2021)" [1], PBC is a chronic progressive autoimmune cholestasis disease that often develops into liver fibrosis and cirrhosis, until liver transplantation or liver transplantation is required.

Note: The original text has been deleted

[1] Source: Chinese Journal of Internal Medicine, 2021,60(8): 709-715.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.